Diego Anazco, MD

PGY-2 @UTSWInternalMed | Research Collaborator @MayoClinicGIHep | MD @USFQ_Ecuador 🇪🇨 | Aspiring GI | #COYG 🔴 | ⚽️ 🏓🧉🤿

[Diego Anazco, MD @danazcomd]

Beyond thrilled to have matched at my dream program! @UTSWInternalMed @UTSWIMchief

Forever grateful for the support from my family, soon-to-be wife, friends, and exceptional mentors @dr_aac @Dr_RADillingham @Pablo_delaC @MDanielaHurtado

Dallas, here we go! 🚀 #Match2024

[Daniel J Drucker @DanielJDrucker]

In people with a suboptimal clinical response after MBS, semaglutide results in substantial and clinically significant body weight reduction along with improvement in metabolic parameters and quality of life, compared to placebo @NatureMedicine https://t.co/cro9e2B9aQ

[Arsenal @Arsenal]

A season to be proud of.

We pushed the boundaries over land and sea, and couldn't have done it without your support. Thank you, Gooners ❤️

[Arsenal @Arsenal]

Arsenal: 2025/26 Premier League champions.

[Arsenal @Arsenal]

The Arsenal. Your Premier League champions.

[Diego Anazco, MD @danazcomd]

Don’t miss this great opportunity! Excited for the upcoming “Coffee with the Expert” session with @JaimeAlmandoz
If you’re interested in obesity medicine, research, or academic mentorship, this is a session you won’t want to miss! ☕️
@ObesitySociety @UTSWInternalMed

[The Obesity Society @ObesitySociety]

☕ Join @JaimeAlmandoz, MD, MBA, for Coffee with the Expert on May 28, 2-3 pm ET! 🔗 Register: https://t.co/SleNbmWVsP #ObesityScience #ObesityMedicine #Mentorship #EarlyCareer #TheObesitySociety @UTSWMedCenter

[Texas Liver Care (TLC) @TexasLiverCare]

Another excellent #DDW2026

Great connecting with colleagues, collaborators & industry partners on advancing liver & metabolic health, expanding clinical trial access, & improving patient care

Thanks to all who took the time to meet with @TexasLiverCare & @EvidentisHQ in Chicago

[Diego Anazco, MD @danazcomd]

Had a blast at #DDW2026 in Chicago! Great reconnecting with friends and mentors, and meeting so many inspiring people. Grateful for the support of amazing mentors and my residency program 🙌
@UTSWIMchief @UTSWInternalMed @UTSWGI @dr_aac @JaimeAlmandoz @DDWMeeting @AmerGastroAssn

[Ariel Aday @ArielAday]

Proud to showcase the incredible work from @UTSWGI at @DDWMeeting! 🔥

📍 50+ lectures & posters 🎤 📊
📍 Faculty, fellows, and trainees leading innovation in GI 🧠

Join us in Chicago and follow along as we share advances in hepatology, IBD, GI oncology, and beyond 💫

[University of Toronto @UofT]

GLP-1 medicine improves liver health independent of weight loss, according to a new study #UofT ➡️ https://t.co/8G3VssYY6n

[Thomas G. Cotter, MD MS @TCotterMD]

Proud to share our latest @AlcHepNet work in @ACERjournal

https://t.co/dXGaOz0Gd8

Among 518 survivors of alcohol-associated hepatitis, >20% returned to drinking by 3 months

AH care must integrate early, proactive AUD treatment

Supports @NIAAAnews ITAALD study rationale

[Gastroenterology @AGA_Gastro]

Phosphatidylethanol (PEth) predicts hepatic decompensation independently of NITs in those at risk of alcohol-related liver disease. Repeated PEth sustains prognostic utility.
🔗 https://t.co/0deS5ZFtuR
@NikolajTorp @AleksanderKrag @IsraelsenMads @MajaThiele

[AASLD @AASLDtweets]

As the role of #GLP1 therapies in #MASLD continues to grow, clinicians need clear guidance.

A new Practice Guidance update in @HEP_Journal provides evidence-based recommendations on using semaglutide therapy for MASH, including patient selection, comorbidity management, and monitoring strategies.

📗 View the update: https://t.co/vMjvwAmxoO

[Maria Alejandra Mendoza, MD @MariAleMendozaD]

So lucky to have worked with my good friend @gioroldanc
This is great work, so proud of you

Clostridioides difficile Infection Among Hospitalized Patients With Cancer https://t.co/uwHREPIReT

[Diego Anazco, MD @danazcomd]

@AdamSalehMD @UTSWInternalMed @UTSWIMchief @GeorgeDoumatMD Congrats Adam!! Amazing group of chiefs! 🙌🏼

[NEJM @NEJM]

The IARC Working Group summarizes guidance on 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 screen-and-treat programs for gastric cancer prevention and concludes that prevention is the most effective strategy amid a rising global burden. Learn more: https://t.co/fyqf8Zd0RV

[Liver Fellow Network @LiverFellow]

#LFNpearls By: @sarachapinMD

⭐️ Immunosuppression after liver transplant: simple in concept, complex in practice.

⭐️ How do you balance rejection, renal function, and malignancy risk?

🔗 https://t.co/HMjxpvq1hT

[Diego Anazco, MD @danazcomd]

@DaniDominguez99 Congrats!! 🇪🇨🇪🇨🇪🇨

[UT Southwestern Internal Medicine @UTSWInternalMed]

The results are in! Join us in congratulating and welcoming our new residents, who will be joining us in July. @UTSWIMchief #UTSWmatch #Match2026

[Diego Anazco, MD @danazcomd]

@GeorgeDoumatMD @UTSWInternalMed @UTSWIMchief Congrats George!! Completely deserved! 🙏

[The Obesity Society @ObesitySociety]

Join Brendon Neuen, MBBS (Hons), MSc (Oxon), PhD, FRACP, FASN, for TOS Coffee with the Expert on March 26, 2026, 4:30 p.m. ET. 🔗 https://t.co/hN5gvX9MqS #ObesityResearch #CardiovascularHealth #EarlyCareerResearchers